Identification of women with an increased risk of developing radiation-induced breast cancer: A case only study

Breast Cancer Research

Volumn 9, Issue 2, 2007, Pages

  Broeks, Annegien ^a   Braaf, Linde M ^a   Huseinovic, Angelina ^a   Nooijen, Anke ^a   Urbanus, Jos ^a   Hogervorst, Frans B L ^a   Schmidt, Marjanka K ^a   Klijn, Jan G M ^b   Russell, Nicola S ^a   Van Leeuwen, Flora E ^a   Van 't Veer, Laura J ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 2; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; FEMALE; GENE IDENTIFICATION; GENE MUTATION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATION RATE; MUTATIONAL ANALYSIS; PROGNOSIS; RADIATION CARCINOGENESIS; RADIATION HAZARD; RISK ASSESSMENT; RISK FACTOR; BREAST TUMOR; DNA DAMAGE; DNA REPAIR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION; RADIATION INJURY; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; CELL CYCLE PROTEINS; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 34250197864     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1668     Document Type: Article

References (45)

1. Antoniou A Pharoah PD Narod S Risch HA Eyfjord JE Hopper JL Loman N Olsson H Johannsson O Borg A Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies Am J Hum Genet 2003, 72:1117-1130 1180265 12677558 10.1086/375033
2. Narod SA Modifiers of risk of hereditary breast and ovarian cancer Nat Rev Cancer 2002, 2:113-123 10.1038/nrc726 12635174
3. Narod SA Foulkes WD BRCA1 and BRCA2: 1994 and beyond Nat Rev Cancer 2004, 4:665-676 10.1038/nrc1431 15343273
4. Andrieu N Easton DF Chang-Claude J Rookus MA Brohet R Cardis E Antoniou AC Wagner T Simard J Evans G Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/ 2 carrier cohort study: A report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group J Clin Oncol 2006, 24:3361-3366 10.1200/ JCO.2005.03.3126 16801631
5. Dumitrescu RG Cotarla I Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med 2005, 9:208-221 10.1111/ j.1582-4934.2005.tb00350.x 15784178
6. Thompson D Duedal S Kirner J McGuffog L Last J Reiman A Byrd P Taylor M Easton DF Cancer risks and mortality in heterozygous ATM mutation carriers J Natl Cancer Inst 2005, 97:813-822 15928302
7. Broeks A Urbanus JH Floore AN Dahler EC Klijn JG Rutgers EJ Devilee P Russell NS van Leeuwen FE van't Veer LJ ATM-heterozygous germline mutations contribute to breast cancer - susceptibility Am J Hum Genet 2000, 66:494-500 1288102 10677309 10.1086/302746
8. Gutierrez-Enriquez S Fernet M Dork T Bremer M Lauge A Stoppa-Lyonnet D Moullan N Angele S Hall J Functional consequences of ATM sequence variants for chromosomal radiosensitivity Genes Chromosomes Cancer 2004, 40:109-119 10.1002/gcc.20025 15101044
9. Smilenov LB Brenner DJ Hall EJ Modest increased sensitivity to radiation oncogenesis in ATM heterozygous versus wild-type mammalian cells Cancer Res 2001, 61:5710-5713 11479203
10. Angele S Romestaing P Moullan N Vuillaume M Chapot B Friesen M Jongmans W Cox DG Pisani P Gerard JP Hall J ATM haplotypes and cellular response to DNA damage: Association with breast cancer risk and clinical radiosensitivity Cancer Res 2003, 63:8717-8725 14695186
11. Vahteristo P Bartkova J Eerola H Syrjakoski K Ojala S Kilpivaara O Tamminen A Kononen J Aittomaki K Heikkila P A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer Am J Hum Genet 2002 71 432 438 379177 12094328 10.1086/341943
12. Offit K Pierce H Kirchhoff T Kolachana P Rapaport B Gregersen P Johnson S Yossepowitch O Huang H Satagopan J Frequency of CHEK2*1100delC in New York breast cancer cases and controls BMC Med Genet 2003, 4:1 149355 12529183 10.1186/1471-2350-4-1
13. Sodha N Bullock S Taylor R Mitchell G Guertl-Lackner B Williams RD Bevan S Bishop K McGuire S Houlston RS Eeles RA CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours Br J Cancer 2002, 87:1445-1448 10.1038/ sj.bjc.6600637 12454775
14. Meijers-Heijboer H van den Ouweland A Klijn J Wasielewski M de Snoo A Oldenburg R Hollestelle A Houben M Crepin E van Veghel-Plandsoen M Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations Nat Genet 2002, 31:55-59 10.1038/ng879 11967536
15. CHEK2 Breast Cancer Case-Control Consortium CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies Am J Hum Genet 2004, 74:1175-1182 1182081 15122511 10.1086/421251
16. Preston DL Mattsson A Holmberg E Shore R Hildreth NG Boice JD Jr Radiation effects on breast cancer risk: A pooled analysis of eight cohorts Radiat Res 2002, 158:220-235 10.1667/ 0033-7587(2002)158[0220:REOBCR]2.0.CO;2 12105993
17. Scott D Chromosomal radiosensitivity and low penetrance predisposition to cancer Cytogenet Genome Res 2004, 104:365-370 10.1159/000077517 15162066
18. Bennett LM Breast cancer: Genetic predisposition an exposure to radiation Mol Carcinog 1999, 26:143-149 10.1002/ (SICI)1098-2744(199911)26:3<143::AID-MC2>3.0.CO;2-S 10559788
19. Boice JD Jr Monson RR Breast cancer in women after repeated fluoroscopic examinations of the chest J Natl Cancer Inst 1977, 59:823-832 894747
20. Morin Doody M Lonstein JE Stovall M Hacker DG Luckyanov N Land CE Breast cancer mortality after diagnostic radiography: Findings from the U.S. Scoliosis Cohort Study Spine 2000, 25:2052-2063 10.1097/ 00007632-200008150-00009 10954636
21. Bernstein JL Teraoka SN John EM Andrulis IL Knight JA Lapinski R Olson ER Wolitzer AL Seminara D Whittemore AS Concannon P The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry Cancer Epidemiol Biomarkers Prev 2006, 15:348-352 10.1158/1055-9965.EPI-05-0557 16492927
22. Harvey EB Brinton LA Second cancer following cancer of the breast in Conneticut, 1935-1982 Natl Cancer Inst Monogr 1985, 68:99-112 4088315
23. Boice JD Jr Harvey EB Blettner M Stovall M Flannery JT Cancer in the contralateral breast after radiotherapy for breast cancer N Engl J Med 1992, 326:781-785 1538720
24. Roychoudhuri R Evans H Robinson D Moller H Radiation-induced malignancies following radiotherapy for breast cancer Br J Cancer 2004, 91:868-872 15292931
25. Haffty BG Radiation therapy and the risk of contralateral breast cancer Int J Radiat Oncol Biol Phys 2003, 56:920-921 10.1016/ S0360-3016(03)00204-9 12829125
26. Rothman KJ Greenland S Case-control studies Modern Epidemiology Philadelphia: Lippincott-Raven Rothman KJ, Greenland S 1998, 615-617
27. Ursin G Henderson BE Haile RW Pike MC Zhou N Diep A Bernstein L Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Res 1997, 57:3678-3681 9288771
28. Sambrook J Fritsch EF Maniatis T Molecular Cloning: A Laboratory Manual Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press 2 1989
29. LOVD http://chromium.liacs.nl/lovd/
30. Breslow NE Day NE Statistical methods in cancer research. The analysis of case-control studies IARC Sci Publ 1980, (32):5-338 7216345
31. Broeks A Braaf LM Huseinovic A Schmidt MK Russell NS Van Leeuwen FE Hogervorst FBL van't Veer LJ The spectrum of ATM missense variants and their contribution to contralateral breast cancer Breast Cancer Res Treat 2007, Mar 28
32. Boice JD Land CE Preston DL Ionizing radiation Cancer Epidemiology and Prevention Schottenfield D, Fraumeni JF Jr New York: Oxford University Press 1996, 319-341
33. Land CE Tokunaga M Koyama K Soda M Preston DL Nishimori I Tokuoka S Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990 Radiat Res 2003, 160:707-717 10.1667/RR3082 14640793
34. Howe GR McLaughlin J Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study Radiat Res 1996, 145:694-707 10.2307/3579360 8643829
35. Broeks A de Witte L Nooijen A Huseinovic A Klijn JG van Leeuwen FE Russell NS van't Veer LJ Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers Breast Cancer Res Treat 2004, 83:91-93 10.1023/B:BREA.0000010697.49896.03 14997059
36. Metcalfe K Lynch HT Ghadirian P Tung N Olivotto I Warner E Olopade OI Eisen A Weber B McLennan J Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 2004, 22:2328-2335 10.1200/ JCO.2004.04.033 15197194
37. Verhoog LC Brekelmans CT Seynaeve C van den Bosch LM Dahmen G van Geel AN Tilanus-Linthorst MM Bartels CC Wagner A van den Ouweland A Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 Lancet 1998, 351:316-321 10.1016/ S0140-6736(97)07065-7 9652611
38. Verhoog LC Brekelmans CT Seynaeve C Meijers-Heijboer EJ Klijn JG Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer Br J Cancer 2000, 83:384-386 10.1054/ bjoc.2000.1239 10917555
39. Schmidt MK Tollenaar RA de Kemp SR Broeks A Cornelisse CJ Smit VT Peterse JL van Leeuwen FE Van 't Veer LJ Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation J Clin Oncol 2007, 25:64-9 10.1200/JCO.2006.06.3024 17132695
40. Ronckers CM Erdmann CA Land CE Radiation and breast cancer: A review of current evidence Breast Cancer Res 2005, 7:21-32 1064116 15642178 10.1186/bcr970
41. Gatti RA Tward A Concannon P Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations Mol Genet Metab 1999, 68:419-423 10.1006/ mgme.1999.2942 10607471
42. Thorstenson YR Roxas A Kroiss R Jenkins MA Yu KM Bachrich T Muhr D Wayne TL Chu G Davis RW Contributions of ATM mutations to familial breast and ovarian cancer Cancer Res 2003, 63:3325-3333 12810666
43. Scott SP Bendix R Chen P Clark R Dork T Lavin MF Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer Proc Natl Acad Sci USA 2002, 99:925-930 117407 11805335 10.1073/pnas.012329699
44. Fu YP Yu JC Cheng TC Lou MA Hsu GC Wu CY Chen ST Wu HS Wu PE Shen CY Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: A multigenic study on cancer susceptibility Cancer Res 2003, 63:2440-2446 12750264
45. Bernstein JL Langholz B Haile RW Bernstein L Thomas DC Stovall M Malone KE Lynch CF Olsen JH Anton-Culver H Study design: Evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study Breast Cancer Res 2004, 6:R199-R214 400669 15084244 10.1186/ bcr771